Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Hoffmann

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 27, 2025
New and Emerging Biological Therapies for Myasthenia Gravis: A Focussed Review for Clinical Decision-MakingLea Gerischer, Paolo Doksani, Sarah Hoffmann, et al.
Experimental Brain Research|August 25, 2009
Replacement of a single cysteine in the fourth transmembrane region of zebrafish pannexin 1 alters hemichannel gating behaviorNora Prochnow, Sarah Hoffmann, Rolf Dermietzel, et al.
Journal of the Neurological Sciences|August 20, 2016
Stroke induces specific alteration of T memory compartment controlling auto-reactive CNS antigen-specific T cell responsesJuliane Klehmet, Sarah Hoffmann, Gerrit Walter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 2, 2012
Decision-making in the diagnosis and treatment of stroke-associated pneumoniaHendrik Harms, Sarah Hoffmann, Uwe Malzahn, et al.
Neuroepidemiology|February 22, 2023
Incidence, Prevalence, Hospitalization Rates, and Treatment Patterns in Myasthenia Gravis: A 10-Year Real-World Data Analysis of German Claims DataHannes Wartmann, Sarah Hoffmann, Tobias Ruck, et al.
The Journal of Membrane Biology|September 23, 2011
Single cysteines in the extracellular and transmembrane regions modulate pannexin 1 channel functionStefanie Bunse, Matthias Schmidt, Sarah Hoffmann, et al.
Muscle & Nerve|July 1, 2026
Fatigue in Myasthenia Gravis: Recent Advances and Emerging ConceptsYvonne J M Campman, Martijn R Tannemaat, Annabel M Ruiter, et al.
Brain and Behavior|October 27, 2016
Fatigue in myasthenia gravis: risk factors and impact on quality of lifeSarah Hoffmann, Johanna Ramm, Ulrike Grittner, et al.
Muscle & Nerve|January 10, 2026
Post Hoc, Sex-Specific Subgroup Analysis of Efgartigimod in Patients With Generalized Myasthenia Gravis From the ADAPT Trial: A Sex and Gender Equity in Research (SAGER) Guidelines ApproachSarah Hoffmann, Sihui Zhao, Filip Callewaert, et al.
Micropublication Biology|June 15, 2026
Microinjected dsRNA triggers a robust RNAi response in <i>Stentor coeruleus</i>Makenna Kuecks, Preeti Arra, Sarah Hoffmann-Weitsman, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 27, 2025
New and Emerging Biological Therapies for Myasthenia Gravis: A Focussed Review for Clinical Decision-MakingLea Gerischer, Paolo Doksani, Sarah Hoffmann, et al.
Experimental Brain Research|August 25, 2009
Replacement of a single cysteine in the fourth transmembrane region of zebrafish pannexin 1 alters hemichannel gating behaviorNora Prochnow, Sarah Hoffmann, Rolf Dermietzel, et al.
Journal of the Neurological Sciences|August 20, 2016
Stroke induces specific alteration of T memory compartment controlling auto-reactive CNS antigen-specific T cell responsesJuliane Klehmet, Sarah Hoffmann, Gerrit Walter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 2, 2012
Decision-making in the diagnosis and treatment of stroke-associated pneumoniaHendrik Harms, Sarah Hoffmann, Uwe Malzahn, et al.
Neuroepidemiology|February 22, 2023
Incidence, Prevalence, Hospitalization Rates, and Treatment Patterns in Myasthenia Gravis: A 10-Year Real-World Data Analysis of German Claims DataHannes Wartmann, Sarah Hoffmann, Tobias Ruck, et al.
The Journal of Membrane Biology|September 23, 2011
Single cysteines in the extracellular and transmembrane regions modulate pannexin 1 channel functionStefanie Bunse, Matthias Schmidt, Sarah Hoffmann, et al.
Muscle & Nerve|July 1, 2026
Fatigue in Myasthenia Gravis: Recent Advances and Emerging ConceptsYvonne J M Campman, Martijn R Tannemaat, Annabel M Ruiter, et al.
Brain and Behavior|October 27, 2016
Fatigue in myasthenia gravis: risk factors and impact on quality of lifeSarah Hoffmann, Johanna Ramm, Ulrike Grittner, et al.
Muscle & Nerve|January 10, 2026
Post Hoc, Sex-Specific Subgroup Analysis of Efgartigimod in Patients With Generalized Myasthenia Gravis From the ADAPT Trial: A Sex and Gender Equity in Research (SAGER) Guidelines ApproachSarah Hoffmann, Sihui Zhao, Filip Callewaert, et al.
Micropublication Biology|June 15, 2026
Microinjected dsRNA triggers a robust RNAi response in <i>Stentor coeruleus</i>Makenna Kuecks, Preeti Arra, Sarah Hoffmann-Weitsman, et al.
Pageof 9